For some of these, EMT-related functions have not yet been found in breast cancer; for example, MFI2 has only been shown to mediate the EMT in melanoma, so further exploration of their roles in the EMT and chemoresistance in breast cancer is worthwhile. This evidence concerns the gene MELTF and melanoma.